Try our beta test site
152 studies found for:    "Cushing disease" OR "Hypercortisolism" OR "Cushing Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Cushing disease" OR "Hypercortisolism" OR "Cushing Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Conditions: Hypercortisolism;   Cushing Syndrome
Interventions: Procedure: Adrenalectomy;   Other: Observation
2 Terminated A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Condition: Cushing's Syndrome
Intervention: Drug: Cushing's syndrome confirmation
3 Completed Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Condition: Mild Hypercortisolism
Intervention: Drug: Mifepristone
4 Recruiting A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing Syndrome
Interventions: Drug: ATR-101;   Drug: Placebos
5 Completed Long Term Post Operative Follow-Up of Cushing Syndrome
Condition: Cushing Syndrome
Intervention:
6 Completed
Has Results
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Conditions: Cushing's Disease;   Cushing's Syndrome
Intervention: Drug: Mifepristone
7 Recruiting Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: CORT125134
8 Completed
Has Results
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
9 Completed
Has Results
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
10 Completed Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Condition: Cushing's Syndrome
Intervention:
11 Recruiting Hypercortisolism and Epicardial Adipose Tissue
Condition: Hypercortisolism
Interventions: Biological: Blood samples for measuring adiponectin, leptin and omentin plasma;   Device: MRI at 3 Tesla
12 Enrolling by invitation Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Other: No intervention
13 Recruiting Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: F-DOPA PET Scan;   Drug: Mifepristone;   Drug: Ga-DOTATATE;   Drug: Octreoscan;   Other: CT, MRI
14 Recruiting Saliva Cortisol Measurement as a Screening Test for Suspicious Cushings Syndrome in Children.
Condition: Cushings Syndrome
Intervention: Other: Children refered to the obesity clinic
15 Recruiting The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis
Condition: Cushing Syndrome
Intervention:
16 Terminated
Has Results
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
Intervention: Drug: Mifepristone
17 Recruiting Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Condition: Cushing's Syndrome
Intervention:
18 Recruiting Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: metyrapone
19 Recruiting Treatment for Endogenous Cushing's Syndrome
Condition: Endogenous Cushing's Syndrome
Intervention: Drug: COR-003
20 Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: Pentetreotide;   Drug: 18-F-fluorodeoxyglucose;   Drug: (18F)-L-3,4-dihydroxyophenylalanine (18F-DOPA)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.